Key result
Hybrid cardiac 68Ga-FAPI-4 PET/MRI enables simultaneous molecular and structural imaging for nonischemic dilated cardiomyopathy.
Why the study?
Does Hybrid Cardiac 68Ga-FAPI-4 PET/MRI enable simultaneous molecular and structural imaging in patients with nonischemic dilated cardiomyopathy?
Does Hybrid Cardiac 68Ga-FAPI-4 PET/MRI enable simultaneous molecular and structural imaging in patients with nonischemic dilated cardiomyopathy?
Hybrid 68Ga-FAPI-4 PET/MRI is a feasible modality for simultaneous molecular and structural imaging in nonischemic dilated cardiomyopathy.
Hybrid imaging feasible in nonischemic dilated cardiomyopathy; hypothesis-generating and requires prospective validation before clinical adoption.
Cardiac gallium 68–labeled fibroblast activation protein inhibitor-4 PET/MRI successfully enabled simultaneous molecular and structural imaging for nonischemic dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question. Hybrid cardiac 68Ga-FAPI-4 PET/MRI successfully enabled simultaneous molecular and structural imaging for nonischemic dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: